Press Release - Remedium Lifecare Limited -Ride the Pharma Wave with Our Rights Issue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Remedium Lifecare Limited (BSE: 539561) has announced a Rights Issue to raise ₹49.19 crores, with a rights issue price of ₹1 per share compared to the closing price of ₹1.79 as on April 25, 2025. The ratio is 61 Rights Equity Shares for every 50 Equity Shares held, with the issue opening on April 30, 2025, and closing on May 14, 2025. The record date for eligibility was April 15, 2025. The capital raise follows a recent ₹182.7 crore agreement with a UK-based pharmaceutical company and will be used to strengthen working capital, R&D (especially in CNS, metabolic, and oncology segments), scale up production of pharmaceutical intermediates, and support global expansion into Europe and Asia.
Existing shareholders can increase their stake at a meaningful discount (~44% below market price), but those who do not subscribe may see their holding diluted. The fund raise supports growth and debt prepayment, which could improve long-term financial strength if execution is successful.